Uchiyama H, Ohara K, Haga K, Haga T, Ichiyama A
Department of Biochemistry, Hamamatsu University School of Medicine, Japan.
J Neurochem. 1990 Jun;54(6):1870-81. doi: 10.1111/j.1471-4159.1990.tb04885.x.
Muscarinic acetylcholine receptors purified from porcine cerebra or atria were covalently labeled with [3H]propylbenzilylcholine mustard ([3H]PrBCM), and then the labeled receptors were subjected to limited hydrolysis with trypsin, V8 protease, and lysyl endopeptidase, followed by analysis involving sodium dodecyl sulfate-polyacrylamide gel electrophoresis, fluorography, autoradiography, or immunostaining. The labeled peptides were located on the basis of their reactivity with antibodies raised against three synthetic peptides with partial sequences of the m1 or m2 receptor, and of their sensitivity to endoglycosidase F, which was taken as evidence that they contain glycosylation sites near the N terminus. The [3H]PrBCM-binding site in both cerebral and atrial receptors was found to be located between the N terminus and the second intracellular loop, because the size of the smallest deglycosylated peptide that contained both the [3H]PrBCM-binding and glycosylation sites was approximately 16 kDa. Cerebral receptors were 32P-phosphorylated with protein kinase C, and the major phosphorylation sites in cerebral muscarinic receptors were found to be located in a C-terminal segment including a part of the third intracellular loop, because a 32P-labeled peptide of 12-14 kDa reacted with anti-(m1 C-terminal peptide) antiserum. The presence of an intramolecular disulfide bond, probably between Cys 98 and Cys 178 in the first and second extracellular loops, respectively, was suggested by the finding that a peptide of approximately 17 kDa containing the [3H]PrBCM-binding site, but not the glycosylation sites, was partly converted to a peptide of approximately 12 kDa on treatment with beta-mercaptoethanol.
从猪脑或心房中纯化的毒蕈碱型乙酰胆碱受体用[³H]丙基苯甲酰胆碱氮芥([³H]PrBCM)进行共价标记,然后将标记的受体用胰蛋白酶、V8蛋白酶和赖氨酰内肽酶进行有限水解,接着进行十二烷基硫酸钠-聚丙烯酰胺凝胶电泳、荧光显影、放射自显影或免疫染色分析。根据标记肽与针对m1或m2受体部分序列的三种合成肽产生的抗体的反应性,以及它们对内切糖苷酶F的敏感性来确定其位置,这被视为它们在N端附近含有糖基化位点的证据。发现脑和心房受体中的[³H]PrBCM结合位点位于N端和第二个细胞内环之间,因为同时包含[³H]PrBCM结合位点和糖基化位点的最小去糖基化肽的大小约为16 kDa。脑受体用蛋白激酶C进行³²P磷酸化,发现脑毒蕈碱受体中的主要磷酸化位点位于包括第三个细胞内环一部分的C端片段中,因为一个12 - 14 kDa的³²P标记肽与抗-(m1 C端肽)抗血清反应。分别在第一和第二细胞外环中可能存在于Cys 98和Cys 178之间的分子内二硫键的存在,是通过以下发现提出的:一个含有[³H]PrBCM结合位点但不含有糖基化位点的约17 kDa的肽在用β-巯基乙醇处理后部分转化为约12 kDa的肽。